Cost of chronic and episodic migraine patients in continuous treatment for two years in a tertiary level headache Centre.

Andrea Negro Paolo SciattellaDaniele RossiMartina Guglielmetti Paolo Martelletti Francesco Saverio Mennini

Published in: The journal of headache and pain (2019)

Our results provide a valuable estimate of the annual direct cost of CM and EM patients in the specific setting of a tertiary headache centre and confirm the high economic impact of migraine on both the NHS and patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
patient safety
patient reported
replacement therapy